MFDS approves CJ HealthCare’s acid reflux treatment ‘K-Cab Tab’ as new drug

Published: 2018-07-09 16:26:00
Updated: 2018-07-09 17:40:34

CJ HealthCare;s acid reflux treatment ‘K-Cab Tab’ acquired approval as a Korean new drug.

The Ministry of Food and Drug Safety(MFDS) acquired approval of CJ HealthCare’s acid reflux treatment ‘K-Cab Tab 50mg(generic name: tegoprazan)’ as a Korean new drug on 5 July.

Indications of the drug appr...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.